TCRT Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-02-22 | Groenewald Ferdinand | 0 | 0 | 0.00 | 0.00 | |||
| 2024-01-20 | Hogue Dale Curtis Jr. | director, officer: Interim CEO | 600,000 | A-Award | A | 600,000 | 0.12 | 72,000.00 |
| 2023-12-29 | Hogue Dale Curtis Jr. | director | 150,000 | A-Award | A | 150,000 | 0.07 | 10,650.00 |
| 2023-12-29 | Hogue Dale Curtis Jr. | director | 41,667 | A-Award | A | 41,667 | 0.07 | 2,958.00 |
| 2023-12-29 | Hogue Dale Curtis Jr. | 0 | 0 | 0.00 | 0.00 | |||
| 2023-09-01 | Boyle Kevin S. Sr. | director, officer: Chief Executive Officer | 798,236 | S-Sale | D | 68,014 | 0.14 | 9,542.00 |
| 2023-06-06 | Postma Robert W | director | 100,000 | A-Award | A | 100,000 | 0.48 | 48,000.00 |
| 2023-06-06 | Hofmeister Robert | director | 100,000 | A-Award | A | 100,000 | 0.48 | 48,000.00 |
| 2023-06-06 | Thistle Mary | director | 100,000 | A-Award | A | 100,000 | 0.48 | 48,000.00 |
| 2023-06-06 | Huang James | director | 100,000 | A-Award | A | 100,000 | 0.48 | 48,000.00 |
| 2023-06-06 | Vieser Jaime | director | 100,000 | A-Award | A | 100,000 | 0.48 | 48,000.00 |
| 2023-06-06 | Weis Holger | director | 100,000 | A-Award | A | 100,000 | 0.48 | 48,000.00 |
| 2023-03-30 | Hofmeister Robert | director | 150,000 | A-Award | A | 150,000 | 0.66 | 99,000.00 |
| 2023-03-30 | Hofmeister Robert | director | 16,667 | A-Award | A | 16,667 | 0.66 | 11,000.00 |
| 2023-03-30 | Hofmeister Robert | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-03-15 | Srivastava Abhishek K | officer: See Remarks | 125,000 | A-Award | A | 125,000 | 0.50 | 62,500.00 |
| 2023-03-15 | Wong Michael | officer: Vice President, Finance | 125,000 | A-Award | A | 125,000 | 0.50 | 62,500.00 |
| 2023-03-15 | Boyle Kevin S. Sr. | director, officer: Chief Executive Officer | 1,800,000 | A-Award | A | 1,800,000 | 0.50 | 900,000.00 |
| 2023-03-15 | Deniger Drew | officer: See Remarks | 125,000 | A-Award | A | 125,000 | 0.50 | 62,500.00 |
| 2023-03-15 | Lackey Melinda | officer: See Remarks | 200,000 | A-Award | A | 200,000 | 0.50 | 100,000.00 |
| 2022-11-29 | Postma Robert W | director | 5,000,000 | P-Purchase | A | 750,000 | 0.65 | 487,500.00 |
| 2022-11-29 | Vieser Jaime | director | 1,250,000 | P-Purchase | A | 1,250,000 | 0.65 | 812,500.00 |
| 2022-09-15 | Deniger Drew | officer: VP, Research and Development | 305,000 | A-Award | A | 305,000 | 2.11 | 643,550.00 |
| 2022-09-15 | Srivastava Abhishek K | officer: See Remarks | 25,000 | A-Award | A | 25,000 | 2.11 | 52,750.00 |
| 2022-09-15 | Wong Michael | officer: VP, Finance | 50,000 | A-Award | A | 50,000 | 2.11 | 105,500.00 |
| 2022-09-15 | Lackey Melinda | officer: Senior Vice President, Legal | 185,000 | A-Award | A | 185,000 | 2.11 | 390,350.00 |
| 2022-08-30 | Boyle Kevin S. Sr. | officer: Chief Executive Officer | 866,250 | F-InKind | D | 18,750 | 2.41 | 45,188.00 |
| 2022-08-12 | Srivastava Abhishek K | officer: See Remarks | 250,000 | A-Award | A | 250,000 | 0.00 | 0.00 |
| 2022-08-03 | Srivastava Abhishek K | officer: See Remarks | 1,200 | D | 0 | 0.00 | 0.00 | |
| 2022-06-22 | Thistle Mary | director: | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2022-06-22 | Thistle Mary | director | 100,000 | A-Award | A | 100,000 | 0.82 | 82,000.00 |
| 2022-06-22 | Huang James | director: | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2022-06-22 | Postma Robert W | director: | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2022-06-22 | Thistle Mary | director: | 45,000 | A-Award | A | 40,000 | 0.00 | 0.00 |
| 2022-06-22 | Huang James | director: | 188,333 | A-Award | A | 80,000 | 0.00 | 0.00 |
| 2022-06-22 | Postma Robert W | director: | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2022-06-22 | Vieser Jaime | director: | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2022-06-22 | Bowden Christopher | director: | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2022-06-22 | Weis Holger | director: | 100,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2022-03-29 | Deniger Drew | officer: VP, Research & Development | 15,000 | D | 0 | 0.00 | 0.00 | |
| 2022-03-29 | Deniger Drew | officer: VP, Research & Development | 0 | D | 50,000 | 4.13 | 206,500.00 | |
| 2022-03-29 | Deniger Drew | officer: VP, Research & Development | 0 | D | 30,000 | 4.72 | 141,600.00 | |
| 2022-03-29 | Deniger Drew | officer: VP, Research & Development | 0 | D | 75,000 | 2.82 | 211,500.00 | |
| 2022-03-29 | Deniger Drew | officer: VP, Research & Development | 0 | D | 35,000 | 4.31 | 150,850.00 | |
| 2022-03-29 | Deniger Drew | officer: VP, Research & Development | 0 | D | 250,000 | 1.50 | 375,000.00 | |
| 2022-03-30 | Boyle Kevin S. Sr. | officer: Chief Executive Officer | 2,000,000 | A-Award | A | 2,000,000 | 0.00 | 0.00 |
| 2022-03-30 | De Groot Eleanor | officer: EVP, Operations | 350,000 | A-Award | A | 350,000 | 0.00 | 0.00 |
| 2022-03-30 | De Groot Eleanor | officer: EVP, Operations | 350,000 | A-Award | A | 350,000 | 0.66 | 231,000.00 |
| 2021-12-22 | De Groot Eleanor | officer: EVP, Operations | 237,106 | S-Sale | D | 20,132 | 1.27 | 25,568.00 |
| 2021-12-10 | Lackey Melinda | officer: Senior Vice President, Legal | 370,000 | A-Award | A | 370,000 | 1.22 | 451,400.00 |
| 2021-11-29 | Lackey Melinda | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2021-11-09 | Wong Michael | officer: Vice President of Finance | 0 | D | 250,000 | 1.64 | 410,000.00 | |
| 2021-11-17 | Boyle Kevin S. Sr. | director, officer: Chief Executive Officer | 885,000 | P-Purchase | A | 9,116 | 1.40 | 12,762.00 |
| 2021-11-16 | Boyle Kevin S. Sr. | director, officer: Chief Executive Officer | 875,884 | P-Purchase | A | 884 | 1.40 | 1,238.00 |
| 2021-09-29 | Vieser Jaime | director | 705,321 | P-Purchase | A | 100,000 | 1.91 | 191,000.00 |
| 2021-09-02 | Hagen Heidi | director | 145,889 | P-Purchase | A | 23,770 | 1.76 | 41,835.00 |
| 2021-09-01 | Weis Holger | director | 120,167 | P-Purchase | A | 50,000 | 1.83 | 91,500.00 |
| 2021-09-02 | Postma Robert W | director | 4,250,000 | P-Purchase | A | 54,492 | 1.73 | 94,271.00 |
| 2021-09-02 | Postma Robert W | director | 1,201,870 | P-Purchase | A | 20,508 | 1.73 | 35,479.00 |
| 2021-09-01 | Huang James | director | 108,333 | P-Purchase | A | 100,000 | 1.71 | 171,000.00 |
| 2021-08-30 | Boyle Kevin S. Sr. | director, officer: Chief Executive Officer | 2,625,000 | A-Award | A | 2,625,000 | 1.64 | 4,305,000.00 |
| 2021-08-30 | Boyle Kevin S. Sr. | director, officer: Chief Executive Officer | 875,000 | A-Award | A | 875,000 | 0.00 | 0.00 |
| 2021-08-30 | Boyle Kevin S. Sr. | director, officer: Chief Executive Officer | 0 | 0 | 0.00 | 0.00 | ||
| 2021-05-17 | Baffa Raffaele | officer: Chief Medical Officer | 280,645 | A-Award | A | 80,645 | 0.00 | 0.00 |
| 2021-03-04 | Weis Holger | director | 150,000 | A-Award | A | 150,000 | 4.31 | 646,500.00 |
| 2021-03-04 | Weis Holger | director | 70,167 | A-Award | A | 4,167 | 0.00 | 0.00 |
| 2021-03-04 | Weis Holger | director | 31,250 | A-Award | A | 31,250 | 4.31 | 134,688.00 |
| 2021-03-04 | Vieser Jaime | director | 605,321 | A-Award | A | 4,167 | 0.00 | 0.00 |
| 2021-03-04 | Vieser Jaime | director | 150,000 | A-Award | A | 150,000 | 4.31 | 646,500.00 |
| 2021-03-04 | Vieser Jaime | director | 31,250 | A-Award | A | 31,250 | 4.31 | 134,688.00 |
| 2021-03-04 | Thistle Mary | director | 150,000 | A-Award | A | 150,000 | 4.31 | 646,500.00 |
| 2021-03-04 | Thistle Mary | director | 37,500 | A-Award | A | 37,500 | 4.31 | 161,625.00 |
| 2021-03-04 | Thistle Mary | director | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2021-03-04 | Postma Robert W | director | 1,181,362 | A-Award | A | 2,500 | 0.00 | 0.00 |
| 2021-03-04 | Postma Robert W | director | 150,000 | A-Award | A | 150,000 | 4.31 | 646,500.00 |
| 2021-03-04 | Postma Robert W | director | 18,750 | A-Award | A | 18,750 | 4.31 | 80,812.00 |
| 2021-03-04 | Huang James | director | 62,500 | A-Award | A | 62,500 | 4.31 | 269,375.00 |
| 2021-03-04 | Huang James | director | 8,333 | A-Award | A | 8,333 | 0.00 | 0.00 |
| 2021-03-04 | BUCHI J KEVIN | director | 31,250 | A-Award | A | 31,250 | 4.31 | 134,688.00 |
| 2021-03-04 | BUCHI J KEVIN | director | 4,167 | A-Award | A | 4,167 | 0.00 | 0.00 |
| 2021-03-04 | Bowden Christopher | director | 31,250 | A-Award | A | 31,250 | 4.31 | 134,688.00 |
| 2021-03-04 | Bowden Christopher | director | 4,167 | A-Award | A | 4,167 | 0.00 | 0.00 |
| 2021-03-22 | Baffa Raffaele | officer: Chief Medical Officer | 200,000 | D | 0 | 0.00 | 0.00 | |
| 2021-03-22 | Baffa Raffaele | officer: Chief Medical Officer | 0 | D | 500,000 | 2.73 | 1,365,000.00 | |
| 2020-12-15 | Weis Holger | director | 66,000 | D | 0 | 0.00 | 0.00 | |
| 2020-12-15 | Weis Holger | director | 19,000 | I | 0 | 0.00 | 0.00 | |
| 2020-12-15 | Weis Holger | director | 1,240 | I | 0 | 0.00 | 0.00 | |
| 2020-12-15 | Weis Holger | director | 1,000 | I | 0 | 0.00 | 0.00 | |
| 2020-12-15 | Weis Holger | director | 200 | I | 0 | 0.00 | 0.00 | |
| 2020-12-15 | Vieser Jaime | director | 601,154 | D | 0 | 0.00 | 0.00 | |
| 2020-12-15 | Vieser Jaime | director | 100,000 | I | 0 | 0.00 | 0.00 | |
| 2020-12-15 | Vieser Jaime | director | 75,000 | I | 0 | 0.00 | 0.00 | |
| 2021-02-05 | Postma Robert W | director | 4,195,508 | I | 0 | 0.00 | 0.00 | |
| 2021-02-05 | Postma Robert W | director | 1,178,862 | D | 0 | 0.00 | 0.00 | |
| 2021-02-05 | Postma Robert W | director | 3,574 | I | 0 | 0.00 | 0.00 | |
| 2021-02-05 | Postma Robert W | director | 0 | D | 946,970 | 0.00 | 0.00 | |
| 2021-03-04 | Buck Jill | officer: EVP, GM Gene Therapy | 236,250 | A-Award | A | 236,250 | 4.31 | 1,018,237.00 |
| 2021-03-04 | Buck Jill | officer: EVP, GM Gene Therapy | 231,016 | A-Award | A | 31,500 | 0.00 | 0.00 |
| 2021-03-04 | Hadfield Robert | officer: Chief Legal Officer and Sec. | 326,250 | A-Award | A | 326,250 | 4.31 | 1,406,137.00 |
| 2021-03-04 | Hadfield Robert | officer: Chief Legal Officer and Sec. | 176,819 | A-Award | A | 43,500 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
